NS 649

Drug Profile

NS 649

Latest Information Update: 22 Aug 1995

Price : $50

At a glance

  • Originator NeuroSearch
  • Class Nootropics; Small molecules
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cognition disorders; Neurological disorders

Most Recent Events

  • 22 Aug 1995 Discontinued-Preclinical for Neurological disorders in Denmark (Unknown route)
  • 22 Aug 1995 Discontinued-Preclinical for Cognition disorders in Denmark (Unknown route)
  • 17 Aug 1995 Investigation in Neurological disorders in Denmark (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top